← Back to Search

CT Scans for Pancreatic and Liver Cancer

N/A

Recruiting

Led By Eugene Koay

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

PANCREATIC CANCER: Non-distant metastatic pancreatic cancer that is either unresectable locally advanced disease or borderline resectable disease

PANCREATIC CANCER: Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4 months

Awards & highlights

Study Summary

This trialtests if CT scans can help predict how well cancer treatment works in people with pancreatic/hepatobiliary cancer.

Who is the study for?

This trial is for adults with non-metastatic pancreatic cancer or hepatobiliary cancer (like liver cancer) who are fit enough for chemotherapy. They must have had or be planned to have CT/MRI scans and agree to use contraception if of childbearing potential. Exclusions include pregnant women, those with serious heart conditions, active infections, other cancers, or any condition that prevents following the study protocol.Check my eligibility

What is being tested?

The trial is testing how well computed tomography (CT) can diagnose and predict treatment responses in patients with pancreatic or hepatobiliary cancers. It involves getting a CT scan and filling out questionnaires to help researchers understand the effectiveness of CT in guiding chemotherapy decisions.See study design

What are the potential side effects?

There may not be direct side effects from participating as this trial focuses on diagnostic procedures rather than treatments. However, typical risks associated with CT scans include exposure to radiation and possible allergic reactions to contrast materials used during imaging.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My pancreatic cancer has not spread far and cannot be removed by surgery or might be difficult to remove.

Select...

I have pancreatic cancer and can carry out all my daily activities without help.

Select...

I have been advised to undergo chemotherapy for pancreatic cancer.

Select...

I have been diagnosed with liver or bile duct cancer.

Select...

I have signed the consent form for the pancreatic cancer study.

Select...

I agree to use birth control and not breastfeed if I have pancreatic cancer and can have children.

Select...

My pancreatic cancer is confirmed to be adenocarcinoma.

Select...

I have liver or bile duct cancer and am fully active or restricted in physically strenuous activity only.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Correlation Between Local Control and Changes in Mass Transport by Computed Tomography (CT)

Trial Design

1Treatment groups

Experimental Treatment

Group I: Computed Tomography Scans (CT)Experimental Treatment2 Interventions

Participants to receive 2 computed tomography (CT) scans that are part of their regular cancer care. One (1) scan performed before the start of chemotherapy, and the other at first restaging visit with oncologist. Participant to complete the MD Anderson Symptom Inventory for Gastrointestinal cancer (MDASI-GI) questionnaire at baseline visit, and follow up visit.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Questionnaire

2014

Completed Phase 2

~20020

Computed Tomography (CT)

2012

N/A

~100

0 / 8Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,666 Previous Clinical Trials

40,925,770 Total Patients Enrolled

M.D. Anderson Cancer CenterLead Sponsor

2,974 Previous Clinical Trials

1,789,087 Total Patients Enrolled

Eugene KoayPrincipal InvestigatorM.D. Anderson Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there vacancies available for individuals to join this clinical trial?

"Clinicialtrials.gov reports that this study is actively enrolling participants, with the original posting on March 9th 2015 and last update from December 16th 2022."

Answered by AI

What upper limit has been placed on the patient participants of this clinical trial?

"Affirmative. According to information available through clinicaltrials.gov, this medical study - which was first posted on March 9th 2015- is actively recruiting participants. 259 individuals are expected to join the trial at a single research site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer

2015. "Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02361320.